Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,456 | 1,184 | 99.9% |
| Education | $19.07 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,133 | 134 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,398 | 64 | $0 (2024) |
| GENZYME CORPORATION | $1,032 | 51 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $938.86 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $935.94 | 121 | $0 (2024) |
| Lilly USA, LLC | $765.02 | 37 | $0 (2024) |
| Galderma Laboratories, L.P. | $687.75 | 54 | $0 (2024) |
| Encore Dermatology Inc. | $675.43 | 41 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $610.53 | 29 | $0 (2024) |
| Dermavant Sciences, Inc. | $571.37 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,379 | 192 | ABBVIE INC. ($463.26) |
| 2023 | $2,820 | 180 | AbbVie Inc. ($509.57) |
| 2022 | $2,476 | 175 | ABBVIE INC. ($451.32) |
| 2021 | $1,160 | 139 | VYNE Pharmaceuticals Inc. ($252.14) |
| 2020 | $1,216 | 108 | VYNE Pharmaceuticals Inc. ($315.06) |
| 2019 | $1,567 | 95 | AbbVie, Inc. ($181.45) |
| 2018 | $1,914 | 125 | Encore Dermatology Inc. ($313.89) |
| 2017 | $1,945 | 173 | Aqua Pharmaceuticals ($343.26) |
All Payment Transactions
1,187 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: DERMATOLOGY | ||||||
| 12/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.37 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Immunology | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,732 | 4,839 | $511,267 | $155,784 |
| 2022 | 19 | 3,439 | 7,305 | $635,799 | $195,537 |
| 2021 | 18 | 3,005 | 6,688 | $536,805 | $173,323 |
| 2020 | 20 | 3,002 | 6,528 | $544,963 | $176,066 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 773 | 958 | $178,188 | $55,429 | 31.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 319 | 359 | $77,903 | $23,558 | 30.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 522 | 614 | $83,504 | $21,167 | 25.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 135 | 141 | $33,276 | $11,285 | 33.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 467 | 2,109 | $29,526 | $10,251 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $24,168 | $6,926 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 62 | $15,686 | $5,750 | 36.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 11 | 12 | $9,377 | $3,650 | 38.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 91 | 94 | $10,810 | $3,121 | 28.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 53 | 72 | $7,920 | $2,767 | 34.9% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 40 | 43 | $9,245 | $2,756 | 29.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 22 | 22 | $6,072 | $2,168 | 35.7% |
| 69100 | Biopsy of ear | Office | 2023 | 29 | 32 | $6,560 | $1,786 | 27.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 24 | 24 | $6,096 | $1,758 | 28.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $4,116 | $1,346 | 32.7% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 12 | 13 | $3,952 | $1,233 | 31.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,788 | $546.86 | 30.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 28 | $812.00 | $208.75 | 25.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 126 | $2,268 | $78.80 | 3.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 891 | 1,166 | $216,876 | $67,361 | 31.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 771 | 948 | $128,928 | $35,807 | 27.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 359 | 409 | $88,753 | $28,110 | 31.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 722 | 3,805 | $53,270 | $18,528 | 34.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 125 | 125 | $28,500 | $8,928 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 88 | $22,264 | $7,590 | 34.1% |
About Chris Crawford, M. D
Chris Crawford, M. D is a Dermatology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447248281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chris Crawford, M. D has received a total of $16,475 in payments from pharmaceutical and medical device companies, with $3,379 received in 2024. These payments were reported across 1,187 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($16,456).
As a Medicare-enrolled provider, Crawford has provided services to 12,178 Medicare beneficiaries, totaling 25,360 services with total Medicare billing of $700,710. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Plano, TX
- Active Since 10/06/2005
- Last Updated 08/05/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1447248281
Products in Payments
- DUPIXENT (Biological) $1,600
- SKYRIZI (Biological) $889.09
- TALTZ (Drug) $603.31
- TREMFYA (Drug) $588.68
- VTAMA (Drug) $571.37
- RINVOQ (Biological) $473.07
- ILUMYA (Biological) $469.89
- Impoyz (Drug) $457.55
- OPZELURA (Drug) $456.32
- DUPIXENT DUPILUMAB INJECTION (Biological) $434.05
- Otezla (Drug) $415.41
- ADBRY (Biological) $406.66
- Humira (Biological) $403.48
- EUCRISA (Drug) $377.03
- DORYX (Drug) $369.87
- COSENTYX (Biological) $341.73
- AMZEEQ (Drug) $312.80
- Zoryve (Drug) $265.71
- Winlevi (Drug) $258.14
- ZILXI (Drug) $254.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Plano
Seemal Desai, Md, MD
Dermatology — Payments: $686,611
Dr. Natalie Wright, M.d, M.D
Dermatology — Payments: $346,490
Sam Awan, M.d, M.D
Dermatology — Payments: $322,018
Dr. Julie Rembold, M.d, M.D
Dermatology — Payments: $21,582
Nicholas Snavely, Md, MD
Dermatology — Payments: $18,034
Dr. Allison Singer, M.d, M.D
Dermatology — Payments: $15,509